Results of GRADE CoE Assessments
The CoE assessments for the efficacy and safety outcomes are presented
in Table 2. Compared to placebo, LR may reduce the symptoms of AD based
on low CoE, and does not cause a significant increase in adverse events
based on moderate CoE.